These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1068 related items for PubMed ID: 25911269
1. Early-phase differences in health-related quality of life, psychological status, and physical function between human leucocyte antigen-haploidentical and other allogeneic haematopoietic stem cell transplantation recipients. Morishita S, Kaida K, Yamauchi S, Wakasugi T, Ikegame K, Kodama N, Ogawa H, Domen K. Eur J Oncol Nurs; 2015 Oct; 19(5):443-50. PubMed ID: 25911269 [Abstract] [Full Text] [Related]
2. Gender differences in health-related quality of life, physical function and psychological status among patients in the early phase following allogeneic haematopoietic stem cell transplantation. Morishita S, Kaida K, Yamauchi S, Wakasugi T, Yoshihara S, Taniguchi K, Ishii S, Ikegame K, Kodama N, Ogawa H, Domen K. Psychooncology; 2013 May; 22(5):1159-66. PubMed ID: 22736382 [Abstract] [Full Text] [Related]
3. Patients receiving HLA-haploidentical/partially matched related allo-HSCT can achieve desirable health-related QoL that is comparable to that of patients receiving HLA-identical sibling allo-HSCT. Mo XD, Xu LP, Liu DH, Chen YH, Han W, Zhang XH, Chen H, Wang Y, Wang JZ, Liu KY, Huang XJ. Bone Marrow Transplant; 2012 Sep; 47(9):1201-5. PubMed ID: 22231459 [Abstract] [Full Text] [Related]
4. Haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of philadelphia chromosome-positive acute lymphoblastic leukemia. Chen H, Liu KY, Xu LP, Chen YH, Han W, Zhang XH, Wang Y, Qin YZ, Liu YR, Huang XJ. Biol Blood Marrow Transplant; 2015 Jun; 21(6):1110-6. PubMed ID: 25698612 [Abstract] [Full Text] [Related]
5. Related HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion: observations of a single Chinese center. Huang X, Liu D. Clin Transpl; 2011 Jun; ():237-45. PubMed ID: 22755417 [Abstract] [Full Text] [Related]
6. Alternative Donor Graft Sources for Adults with Hematologic Malignancies: A Donor for All Patients in 2017! Kindwall-Keller TL, Ballen KK. Oncologist; 2017 Sep; 22(9):1125-1134. PubMed ID: 28546462 [Abstract] [Full Text] [Related]
7. Relationship of physical activity with physical function and health-related quality of life in patients having undergone allogeneic haematopoietic stem-cell transplantation. Morishita S, Kaida K, Yamauchi S, Wakasugi T, Ikegame K, Ogawa H, Domen K. Eur J Cancer Care (Engl); 2017 Jul; 26(4):. PubMed ID: 28220548 [Abstract] [Full Text] [Related]
8. A decision analysis of allogeneic hematopoietic stem cell transplantation in adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia in first remission who have an HLA-matched sibling donor. Kako S, Morita S, Sakamaki H, Ogawa H, Fukuda T, Takahashi S, Kanamori H, Onizuka M, Iwato K, Suzuki R, Atsuta Y, Kyo T, Sakura T, Jinnai I, Takeuchi J, Miyazaki Y, Miyawaki S, Ohnishi K, Naoe T, Kanda Y. Leukemia; 2011 Feb; 25(2):259-65. PubMed ID: 21072046 [Abstract] [Full Text] [Related]
9. Incidence of invasive fungal disease after unmanipulated haploidentical stem cell transplantation was significantly higher than that after HLA-matched sibling transplantation. Sun Y, Xu L, Liu D, Zhang X, Han W, Wang Y, Chen H, Chen Y, Wang F, Wang J, Ji Y, Tang F, Liu K, Huang XJ. Clin Microbiol Infect; 2013 Nov; 19(11):1029-34. PubMed ID: 23565830 [Abstract] [Full Text] [Related]
10. The quality of life following allogeneic hematopoietic stem cell transplantation - a multicenter retrospective study. Valkova V, Jircikova J, Trnkova M, Steinerova K, Keslova P, Lanska M, Koristek Z, Raida L, Krejci M, Kruntoradova K, Dolezal T, Benesova K, Cetkovsky P, Trneny M. Neoplasma; 2016 Nov; 63(5):743-51. PubMed ID: 27468878 [Abstract] [Full Text] [Related]
11. Unmanipulated haploidentical haematopoietic stem cell transplantation for children with severe aplastic anaemia. Zhu H, Luo RM, Luan Z, Lee V, Zhu YP, Luo CJ, Tang XF, Si YJ, Chen J. Br J Haematol; 2016 Sep; 174(5):799-805. PubMed ID: 27263533 [Abstract] [Full Text] [Related]
12. Safety and feasibility of physical therapy in cytopenic patients during allogeneic haematopoietic stem cell transplantation. Morishita S, Kaida K, Setogawa K, Kajihara K, Ishii S, Ikegame K, Kodama N, Ogawa H, Domen K. Eur J Cancer Care (Engl); 2013 May; 22(3):289-99. PubMed ID: 23252444 [Abstract] [Full Text] [Related]
13. Transplantation for thalassemia major: alternative donors. Locatelli F, Merli P, Strocchio L. Curr Opin Hematol; 2016 Nov; 23(6):515-523. PubMed ID: 27537474 [Abstract] [Full Text] [Related]
14. Long-term survivors demonstrate superior quality of life after haploidentical stem cell transplantation to matched sibling donor transplantation. Zhang X, Wang J, Liu Y, Liu J, Wang B, Zhang Q, Guan W, Zhang H, Xu L, Liu G, Zhang P, He Y, Feng S, Han M, Li C, Jiang E, Xie W. J Transl Med; 2022 Dec 14; 20(1):596. PubMed ID: 36517908 [Abstract] [Full Text] [Related]
15. Transplantation from haploidentical donor is not inferior to that from identical sibling donor for patients with chronic myeloid leukemia in blast crisis or chronic phase from blast crisis. Ma YR, Huang XJ, Xu ZL, Liu KY, Chen H, Zhang XH, Han W, Chen YH, Wang FR, Wang JZ, Wang Y, Chen Y, Yan CH, Xu LP. Clin Transplant; 2016 Sep 14; 30(9):994-1001. PubMed ID: 27292967 [Abstract] [Full Text] [Related]
16. [Allogeneic hematopoietic stem cell transplantation from HLA one-locus-mismatched related donors]. Hyo R, Taguchi J, Kamijo A, Tanaka M, Hashimoto C, Kanamori H, Motomura S, Maruta A, Ishigatsubo Y. Gan To Kagaku Ryoho; 2009 Nov 14; 36(11):1845-9. PubMed ID: 19920386 [Abstract] [Full Text] [Related]
17. Impact of human leucocyte antigen mismatch on graft-versus-host disease and graft failure after reduced intensity conditioning allogeneic haematopoietic stem cell transplantation from related donors. Teshima T, Matsuo K, Matsue K, Kawano F, Taniguchi S, Hara M, Hatanaka K, Tanimoto M, Harada M, Nakao S, Abe Y, Wake A, Eto T, Takemoto Y, Imamura M, Takahashi S, Ishida Y, Kanda Y, Kasai M, Takaue Y. Br J Haematol; 2005 Aug 14; 130(4):575-87. PubMed ID: 16098073 [Abstract] [Full Text] [Related]
18. [Allogeneic hematopoietic stem cell transplantation for acute myeloblastic leukemia in first remission]. Bondarenko SN, Semenova EV, Vavilov VN, Stancheva NV, Morozova EV, Alianskiĭ AL, Babenko EV, Osipova NÉ, Zubarovskaia LS, Afanas'ev BV. Ter Arkh; 2013 Aug 14; 85(7):18-25. PubMed ID: 24137943 [Abstract] [Full Text] [Related]
19. Long-term outcomes of HLA-matched sibling compared with mismatched related and unrelated donor hematopoietic stem cell transplantation for chronic phase chronic myelogenous leukemia: a single institution experience in China. Liu QF, Xu XJ, Chen YK, Sun J, Zhang Y, Fan ZP, Xu D, Jiang QL, Wei YQ, Huang F, Feng R, Liu XL, Xu B, Meng FY. Ann Hematol; 2011 Mar 14; 90(3):331-41. PubMed ID: 20872002 [Abstract] [Full Text] [Related]
20. HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for chronic myeloid leukemia: improved outcomes in patients in accelerated phase and blast crisis phase. Xiao-Jun H, Lan-Ping X, Kai-Yan L, Dai-Hong L, Huan C, Wei H, Yu-Hong C, Jing-Zhi W, Yao C, Xiao-Hui Z, Hong-Xia S, Dao-Pei L. Ann Med; 2008 Mar 14; 40(6):444-55. PubMed ID: 18608121 [Abstract] [Full Text] [Related] Page: [Next] [New Search]